| Product NDC: | 58407-625 |
| Proprietary Name: | STAHIST AD |
| Non Proprietary Name: | CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE |
| Active Ingredient(s): | 25; 60 mg/1; mg/1 & nbsp; CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 58407-625 |
| Labeler Name: | Magna Pharmaceuticals, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20111220 |
| Package NDC: | 58407-625-30 |
| Package Description: | 1 BOTTLE in 1 BOX (58407-625-30) > 30 TABLET in 1 BOTTLE |
| NDC Code | 58407-625-30 |
| Proprietary Name | STAHIST AD |
| Package Description | 1 BOTTLE in 1 BOX (58407-625-30) > 30 TABLET in 1 BOTTLE |
| Product NDC | 58407-625 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | CHLORCYCLIZINE HYDROCHLORIDE and PSEUDOEPHEDRINE HYDROCHLORIDE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20111220 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Magna Pharmaceuticals, Inc. |
| Substance Name | CHLORCYCLIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Strength Number | 25; 60 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |